^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    SAR566658

    i
    Company:
    AbbVie, Sanofi
    Drug class:
    Microtubule inhibitor, CA6-targeted antibody-drug conjugate
    Related drugs:
    Apply
    First in Man Study of SAR566658 Administered in Patients With CA6-Positive and Refractory Solid Tumor (NCT01156870)
    Phase 1
    Sanofi
    Completed
    Last update posted :
    05/10/2017
    Initiation :
    09/08/2010
    Primary completion :
    04/07/2017
    Completion :
    04/07/2017
    CA6
    |
    SAR566658